Evidence map›Paper›PMID 29535356›Full record

ArticleScientific reports2018

Enhanced features of Dictyoglomus turgidum Cellulase A engineered with carbohydrate binding module 11 from Clostridium thermocellum.

Chiara Cattaneo, Patrizia Cesaro, Stefano Spertino, Sara Icardi, Maria Cavaletto

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chiara CattaneoUniversity of Piemonte Orientale, Dipartimento di Scienze e Innovazione Tecnologica Complesso Universitario S. Giuseppe, Piazza S. Eusebio 5, Vercelli, 13100, Italy.
Patrizia CesaroUniversity of Piemonte Orientale, Dipartimento di Scienze e Innovazione Tecnologica Viale T. Michel 11, Alessandria, 15121, Italy.
Stefano SpertinoUniversity of Piemonte Orientale, Dipartimento di Scienze e Innovazione Tecnologica Viale T. Michel 11, Alessandria, 15121, Italy.
Sara IcardiUniversity of Piemonte Orientale, Dipartimento di Scienze e Innovazione Tecnologica Viale T. Michel 11, Alessandria, 15121, Italy.
Maria CavalettoUniversity of Piemonte Orientale, Dipartimento di Scienze e Innovazione Tecnologica Complesso Universitario S. Giuseppe, Piazza S. Eusebio 5, Vercelli, 13100, Italy. maria.cavaletto@uniupo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignocellulosic biomass (LCB) is a low-cost and abundant source of fermentable sugars. Enzymatic hydrolysis is one of the main ways to obtain sugars from biomass, but most of the polysaccharide-degrading enzymes are poorly efficient on LCB and cellulases with higher performances are required. In this study, we designed a chimeric protein by adding the carbohydrate binding module (CBM) of the cellulosomal enzyme CtLic26A-Cel5E (endoglucanase H or CelH) from Clostridium (Ruminiclostridium) thermocellum to the C-terminus of Dtur CelA, an interesting hyperthermostable endoglucanase from Dictyoglomus turgidum. The activity and binding rate of both native and chimeric enzyme were evaluated on soluble and insoluble polysaccharides. The addition of a CBM resulted in a cellulase with enhanced stability at extreme pHs, higher affinity and activity on insoluble cellulose.

Indexed as

Carbohydrate MetabolismAcetivibrio thermocellusAmino Acid SequenceBase SequenceCellulaseEnzyme ActivationGene ExpressionGenetic EngineeringHydrogen-Ion ConcentrationKineticsRecombinant Fusion ProteinsSolubilityTemperatureCellulaseRecombinant Fusion Proteins

Identifiers

PMID29535356
PMCPMC5849603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.